Intervacc's distribution partner Dechra launches Strangvac in Finland

Intervacc AB announces that its distribution partner, Dechra Pharmaceuticals PLC, will launch the Strangvac vaccine in Finland. This follows an extended collaboration, allowing Dechra to sell Strangvac in the country. The vaccine, approved for sale in the EU and other regions, aims to enhance the approach to equine strangles. Dechra, a specialist in veterinary pharmaceuticals, is excited to add Strangvac to its product range. The launch reflects Dechra's strong presence in Finland and aims to reach more veterinarians and horse owners.